Literature DB >> 18977782

Using retroviruses as a mutagenesis tool to explore the zebrafish genome.

Li-En Jao1, Lisette Maddison, Wenbiao Chen, Shawn M Burgess.   

Abstract

We review different uses of the retroviral mutagenesis technology as the tool to manipulate the zebrafish genome. In addition to serving as a mutagen in a phenotype-driven forward mutagenesis screen as it was originally adapted for, retroviral insertional mutagenesis can also be exploited in reverse genetic approaches, delivering enhancer- and gene-trap vectors for the purpose of examining gene expression patterns and mutagenesis, making sensitized mutants amenable for chemical and genetic modifier screens, and producing gain-of-function mutations by epigenetically overexpressing the retroviral-inserted genes. From a technology point of view, we also summarize the recent advances in the high-throughput cloning of retroviral integration sites, a pivotal step toward identifying mutations. Lastly, we point to some potential directions that retroviral mutagenesis might take from the lessons of studying other model organisms.

Entities:  

Mesh:

Year:  2008        PMID: 18977782      PMCID: PMC2722255          DOI: 10.1093/bfgp/eln038

Source DB:  PubMed          Journal:  Brief Funct Genomic Proteomic        ISSN: 1473-9550


  77 in total

1.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

Review 2.  Conditional control of gene expression in the mouse.

Authors:  M Lewandoski
Journal:  Nat Rev Genet       Date:  2001-10       Impact factor: 53.242

3.  Target-selected gene inactivation in zebrafish.

Authors:  Erno Wienholds; Ronald H A Plasterk
Journal:  Methods Cell Biol       Date:  2004       Impact factor: 1.441

Review 4.  Mutagenesis strategies in zebrafish for identifying genes involved in development and disease.

Authors:  Adam Amsterdam; Nancy Hopkins
Journal:  Trends Genet       Date:  2006-07-17       Impact factor: 11.639

Review 5.  Retroviral insertional mutagenesis: past, present and future.

Authors:  A G Uren; J Kool; A Berns; M van Lohuizen
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

6.  Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells.

Authors:  B P Zambrowicz; G A Friedrich; E C Buxton; S L Lilleberg; C Person; A T Sands
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

7.  Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish.

Authors:  S Lin; N Gaiano; P Culp; J C Burns; T Friedmann; J K Yee; N Hopkins
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

Review 8.  Integration target site selection for retroviruses and transposable elements.

Authors:  X Wu; S M Burgess
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

9.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

10.  Gain-of-function screen for genes that affect Drosophila muscle pattern formation.

Authors:  Nicole Staudt; Andreas Molitor; Kalman Somogyi; Juan Mata; Silvia Curado; Karsten Eulenberg; Martin Meise; Thomas Siegmund; Thomas Häder; Andres Hilfiker; Günter Brönner; Anne Ephrussi; Pernille Rørth; Stephen M Cohen; Sonja Fellert; Ho-Ryun Chung; Olaf Piepenburg; Ulrich Schäfer; Herbert Jäckle; Gerd Vorbrüggen
Journal:  PLoS Genet       Date:  2005-10-28       Impact factor: 5.917

View more
  22 in total

Review 1.  Investigating the genetics of visual processing, function and behaviour in zebrafish.

Authors:  Sabine L Renninger; Helia B Schonthaler; Stephan C F Neuhauss; Ralf Dahm
Journal:  Neurogenetics       Date:  2011-01-26       Impact factor: 2.660

2.  A model of Costeff Syndrome reveals metabolic and protective functions of mitochondrial OPA3.

Authors:  Wuhong Pei; Lisa E Kratz; Isa Bernardini; Raman Sood; Tohei Yokogawa; Heidi Dorward; Carla Ciccone; Richard I Kelley; Yair Anikster; Harold A Burgess; Marjan Huizing; Benjamin Feldman
Journal:  Development       Date:  2010-08-01       Impact factor: 6.868

Review 3.  Zebrafish: a model for the study of addiction genetics.

Authors:  Eric W Klee; Henning Schneider; Karl J Clark; Margot A Cousin; Jon O Ebbert; W Michael Hooten; Victor M Karpyak; David O Warner; Stephen C Ekker
Journal:  Hum Genet       Date:  2011-12-30       Impact factor: 4.132

4.  Generating conditional mutations in zebrafish using gene-trap mutagenesis.

Authors:  Lisette A Maddison; Jianjun Lu; Wenbiao Chen
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

Review 5.  Advances in mRNA silencing and transgene expression: a gateway to functional genomics in schistosomes.

Authors:  Elissaveta Tchoubrieva; Bernd Kalinna
Journal:  Biotechnol Genet Eng Rev       Date:  2010

6.  Zebrafish: a model system to study heritable skin diseases.

Authors:  Qiaoli Li; Michael Frank; Christine I Thisse; Bernard V Thisse; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2010-12-30       Impact factor: 8.551

7.  Schwann cells and deleted in colorectal carcinoma direct regenerating motor axons towards their original path.

Authors:  Allison F Rosenberg; Jesse Isaacman-Beck; Clara Franzini-Armstrong; Michael Granato
Journal:  J Neurosci       Date:  2014-10-29       Impact factor: 6.167

8.  Mirror movement-like defects in startle behavior of zebrafish dcc mutants are caused by aberrant midline guidance of identified descending hindbrain neurons.

Authors:  Roshan A Jain; Hannah Bell; Amy Lim; Chi-Bin Chien; Michael Granato
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

9.  Conditional gene-trap mutagenesis in zebrafish.

Authors:  Lisette A Maddison; Mingyu Li; Wenbiao Chen
Journal:  Methods Mol Biol       Date:  2014

Review 10.  Progress and prospects: techniques for site-directed mutagenesis in animal models.

Authors:  Z Yan; X Sun; J F Engelhardt
Journal:  Gene Ther       Date:  2009-02-19       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.